About
Technology
Issues
FAQ
Links
Official Page
Pemetrexed versus gefitinib as a second-line treatment in advanced nonsquamous nonsmall-cell lung cancer patients harboring wild-type EGFR (CTONG0806): a multicenter randomized trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.